Mycobacterium tuberculosis: immune response, biomarkers, and therapeutic intervention

L Zhuang, L Yang, L Li, Z Ye, W Gong - MedComm, 2024‏ - Wiley Online Library
Although tuberculosis (TB) is an infectious disease, the progression of the disease following
Mycobacterium tuberculosis (MTB) infection is closely associated with the host's immune …

Personalised medicine for tuberculosis and non-tuberculous mycobacterial pulmonary disease

K Kumar, OM Kon - Microorganisms, 2021‏ - mdpi.com
Personalised medicine, in which clinical management is individualised to the genotypic and
phenotypic data of patients, offers a promising means by which to enhance outcomes in the …

Defining the role of cellular immune signatures in diagnostic evaluation of suspected tuberculosis

A Halliday, T Masonou… - The Journal of …, 2022‏ - academic.oup.com
Background Diagnosis of paucibacillary tuberculosis (TB) including extrapulmonary TB is a
significant challenge, particularly in high-income, low-incidence settings. Measurement of …

Mycobacterium tuberculosis

YY Li, RJ Cai, EA Talbot, YT Wang - Molecular Medical Microbiology, 2024‏ - Elsevier
Mycobacterium tuberculosis is the causative pathogen of tuberculosis (TB), an ancient
disease that continues to tremendously impact global human health. Rapid and accurate …